Navigation Links
Blood tests and better communication skills could cut over-prescribing of antibiotics
Date:5/21/2009

Improving communications skills and the use of a simple blood test could help cut the growing number of inappropriate prescriptions of antibiotics, a joint Cardiff University trial has discovered.

In a major new clinical trial, published in the British Medical Journal, a team of researchers from Cardiff University's School of Medicine together with researchers from the Maastricht University Medical Centre in the Netherlands found those GPs in primary care who underwent training in advanced communications skills and those who made use of a simple blood test prescribed fewer antibiotics for lower respiratory tract infections, which generally do not respond to antibiotics.

Professor Christopher Butler, Head of Department of Primary Care and Public Health at Cardiff University who led the trial, said: "As the problem of bacteria resistant to antibiotic treatment grows, researchers from around the world are seeking ways to improve the quality of antibiotic prescribing. Prescribing antibiotics only when patients will clearly benefit, reduces the pressure that drives antibiotic resistance.

"Conditions like acute bronchitis account for some 80% of all lower respiratory tract infections and despite evidence of little or no benefit from antibiotics, the majority of these patients are still prescribed antibiotics.

"We know that with the many pressures facing GPs, including worry about leaving pneumonia untreated, they often give patients "the benefit of the doubt" and prescribe antibiotics. Our clinical trial therefore sought to evaluate ways antibiotic prescribing could be reduced without adversely affecting patient recovery or satisfaction with care."

The trial evaluated an 'illness focussed' approach, where clinicians seek to better understand the patient's illness experience and communicate more effectively about management, and a 'disease focussed' approach, where clinicians focus on diagnosis, in this case, a simple point-of-care blood test.

The trial randomised 20 general practices in the Netherlands, where 40 GPs managed 431 patients with lower respiratory tract infection.

Dr Kerry Hood, Director of the South East Wales Trials Unit said, "The results showed that 54% of GPs practising according to usual care prescribed antibiotics, whereas 27% of those who had been trained in the advanced communication and 31% of the GPs who used the blood test methods did so. Only 23% of GPs who were trained in the advanced communication skills and who used the blood test prescribed antibiotics."

Professor Butler added, "This international collaboration between primary care researchers from Cardiff and Maastricht has shown that both an 'illness focussed' and a 'disease focussed' approach were effective in reducing antibiotic prescribing, but the two approaches combined give the greatest benefit. We need to both communicate better and improve diagnosis to do the best for our patients and to preserve antibiotic effectiveness for our children.

"Importantly, the results showed that prescribing fewer antibiotics did not mean that patients were unwell for longer. Patient's recovery and satisfaction with care were not compromised by GPs not prescribing their patient antibiotics."


'/>"/>

Contact: Dr. Christopher C. Butler
ButlerCC@cardiff.ac.uk
44-292-068-7168
Cardiff University
Source:Eurekalert

Related medicine news :

1. Cord Blood America, Inc. Announces 2009 First Quarter Results
2. Research points to a new way to protect kidneys threatened by insufficient blood or toxins
3. Cord Blood America CEO Matthew Schissler Expands on Thought Process in Owning Stem Cell Laboratory
4. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
5. Viral Infection Might Trigger High Blood Pressure
6. Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory
7. New research confirms milestone study on blood pressure meds
8. AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
9. Study finds iron levels not predictive of survival for form of blood cancer
10. Genes Yield Clues to High Blood Pressure
11. Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful for Garden Media ... All through the year, Garden Media aims to provide material helpful to clients’ goals ... pitching client’s key messages to gain coveted media placements, Garden Media wows ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet ... a conversation on the current obstacles facing infection prevention and offer strategies for ... caused by these infections. , The print component of “Fighting Infection” is ...
(Date:3/24/2017)... ... ... According to a new study by NCPA Senior Fellow John R. Graham, ... Congress has directed the CBO to follow. The CBO itself previously recognized Obamacare would ... estimates a reduction in employer-based coverage due to the GOP reform, which is not ...
(Date:3/24/2017)... ... March 24, 2017 , ... Shamanic healer and teacher ... Healing and Spiritual Awakening, proudly presents her Sacred Peru retreat with world ... and spiritual journey during the Summer Solstice will also be her final international ...
(Date:3/24/2017)... CA (PRWEB) , ... March 24, 2017 , ... ... on two panels at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, ... Creating the Administrative Record, The majority of cases litigated under ERISA involve claims ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017 Summary ... disease pipeline guide Primary Hyperoxaluria - Pipeline Review, ... Hyperoxaluria (Genito Urinary System And Sex Hormones) pipeline ... characterized by recurrent kidney and bladder stones. It ... oxalate. Symptoms include blood in the urine, pain ...
(Date:3/23/2017)... and VANCOUVER, British Columbia ... SPHS ) (the "Company" or "Sophiris"), a ... treatment of urological diseases, today announced that data from ... the drug as a focal treatment for localized prostate ... 26, 2017 at the 32 nd Annual European ...
(Date:3/23/2017)...   Icertis , the leading provider of ... today announced an upgrade to the Icertis Clinical ... clinical trials contract management. Built on the ... speeds up clinical trial contracting while improving collaboration ... "The pharmaceutical industry is under intense ...
Breaking Medicine Technology: